Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

Item

http://www.wikidata.org/entity/Q39445047

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@en

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@nl

type

Item

label

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@en

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@nl

prefLabel

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@en

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@nl

P1476

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

@en

P2093

David R Luke

http://www.w3.org/2001/XMLSchema#string

Laura E Lawrence

http://www.w3.org/2001/XMLSchema#string

Megan Quintas

http://www.w3.org/2001/XMLSchema#string

Randall Hoover

http://www.w3.org/2001/XMLSchema#string

Richard A Preston

http://www.w3.org/2001/XMLSchema#string

Sue K Cammarata

http://www.w3.org/2001/XMLSchema#string

Susan K Paulson

http://www.w3.org/2001/XMLSchema#string

Thomas C Marbury

http://www.w3.org/2001/XMLSchema#string

P2860

UDP-Glucuronosyltransferases

Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy

Surgery and portal hypertension.

Transection of the oesophagus for bleeding oesophageal varices.

Conjugation pathways in liver disease.

Delafloxacin for the treatment of respiratory and skin infections.

A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

Organ Impairment-Drug-Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs.

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections.

Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.

P304

328-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.817

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27570245

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

5324641

http://www.w3.org/2001/XMLSchema#string